Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [21] Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy
    Rasmussen, Thomas A.
    Tolstrup, Martin
    Melchjorsen, Jesper
    Frederiksen, Christian A.
    Nielsen, Ulla S.
    Langdahl, Bente L.
    Ostergaard, Lars
    Laursen, Alex L.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [22] Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
    Cid-Silva, Purificacion
    Fernandez-Bargiela, Noelia
    Margusino-Framinan, Luis
    Balboa-Barreiro, Vanesa
    Mena-De-Cea, Alvaro
    Lopez-Calvo, Soledad
    Vazquez-Rodriguez, Pilar
    Martin-Herranz, Isabel
    Miguez-Rey, Enrique
    Poveda, Eva
    Castro-Iglesias, Angeles
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (04) : 479 - 490
  • [23] The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity
    Klassen, Karen
    Martineau, Adrian R.
    Wilkinson, Robert J.
    Cooke, Graham
    Courtney, Alan P.
    Hickson, Mary
    PLOS ONE, 2012, 7 (09):
  • [24] Predictors of Kidney Tubular Dysfunction in HIV-Infected Patients Treated with Tenofovir: A Pharmacogenetic Study
    Rodriguez-Novoa, Sonia
    Labarga, Pablo
    Soriano, Vincent
    Egan, Deirdre
    Albalater, Marta
    Morello, Judit
    Cuenca, Lorena
    Gonzalez-Pardo, Gema
    Khoo, Saye
    Back, David
    Owen, Andrew
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (11) : E108 - E116
  • [25] Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir
    Casado, Jose L.
    Banon, Sara
    Santiuste, Carmen
    Serna, Jorge
    Guzman, Paula
    Tenorio, Maite
    Liano, Fernando
    del Rey, Jose M.
    AIDS, 2016, 30 (02) : 231 - 239
  • [26] The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population
    Bekolo, Cavin Epie
    Nguena, Modestine Becker
    Ewane, Leonard
    Bekoule, Patrick Sylvestre
    Kollo, Basile
    BMC PUBLIC HEALTH, 2014, 14
  • [27] Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
    Lis, Anna
    Lis, Paulina
    Lowicka, Weronika
    Grabarczyk, Malgorzata
    Wita, Michal
    Zarczynski, Piotr
    Zarczynska, Malgorzata
    Haberka, Maciej
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (08)
  • [28] HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients
    Kotler, Donald P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 : S79 - S85
  • [29] Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia
    Stefanutti, Claudia
    Mazza, Fabio
    MEDICINAL CHEMISTRY, 2012, 8 (06) : 1171 - 1181
  • [30] Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review
    Souza, Suelen Jorge
    Luzia, Liania Alves
    Santos, Sigrid Sousa
    Carvalho Rondo, Patricia Helen
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (02): : 186 - 198
12345